The Lactate Project: Investigating the Impact of Lactate to Preserve Vital Organ Blood Supply and Function in Heart and Brain

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-75
SponsorUniversity of Aarhus

About this trial

The aim of the proposed study is to investigate the effect of increased plasma lactate concentrations on the heart and brain's metabolism of other energy sources, primarily glucose in the brain and glucose and FFA in the heart.

The investigator hypothesize that:

* An acute increase in lactate plasma concentration will decrease cerebral glucose uptake and increase cerebral blood flow * An acute increase in lactate plasma concentration will decrease palmitate and glucose uptake in the myocardium, and increase myocardial perfusion

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 55-75 years

Male or postmenopausal female

BMI 20-35 kg/m2

Signed informed consent form

Disqualifiers

Clinically significant heart, lung, kidney, kidney, liver, endocrine or malignant disease basedon information obtained during an initial screening visit as well as blood samples and an ECG.

Blood donation within the last 3 months

Smoking

Alcohol- or substance abuse

Trial design

Design model

Crossover

Treatments tested in this trial

  • Sodium Lactate Solution

    Other intervention

    Infusion of sodium-lactate solution

  • Saline infusion (placebo)

    Other intervention

    NaCl solution

Treatment groups

8 Participants
are divided into 2 treatment groups
Group A: Na-Lactate infusionExperimental treatment 1 intervention
Group B: Saline infusion (Placebo)Placebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Cerebral glucose uptake

Cerebral glucose uptake (\[18F\]FDG PET scan) under basal and hyperinsulinemic- euglycemic conditions (clamp conditions).

Time frame
From T=300-360 (minutes)

Secondary outcomes

1

Cerebral blood flow

Cerebral blood flow (\[15O\]H2O PET scan)

Time frame
T = 0-10 (minutes)
2

Myocardial perfusion

Myocardial perfusion (\[15O\]H2O PET scan)

Time frame
T = 0-10 (minutes)
3

Myocardial glucose uptake

Myocardial glucose uptake (\[18F\]FDG PET scan)

Time frame
T = 300-360 (minutes)
4

Myocardial FFA uptake and oxidation

Myocardial FFA uptake and oxidation (\[11C\]Palmitate PET scan)

Time frame
T = 30-70 (minutes)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Aarhus

Lead sponsor

Aarhus University Hospital

Collaborator

This trial is not recruiting at the moment. You can still explore other options: